Roche Lebanon S.A.R.L. in collaboration with Roche Diagnostics Middle East FZCO (“Roche”) have the pleasure of inviting you to attend the webinar series on SARS-CoV-2 serology testing: Session 5: “Importance of Elecsys Antibody Testing in the context of SARS-CoV-2 Vaccines”
World Health Organization (WHO) has declared the coronavirus outbreak (COVID-19; caused by the virus SARS-CoV-2) as a pandemic. The rapidly increasing demand on health facilities and laboratories threatens to leave some health systems overstretched and unable to operate effectively. The series of webinars help to address those points.
Objectives and Key takeaways:
Highlighting the Role of Ab testing and COVID-19 Vaccine
Enlighten the correlation of Elecsys Anti-SARS CoV-2 S assay with virus-neutralizing capacity – based on latest data and evidence
Emerging evidence on SARS CoV 2 testing in the context of Vaccination
Do you have a question on Antibody testing for COVID-19? Ask the Experts in live Q&A session
Importance of Elecsys Antibody Testing in the context of SARS-CoV-2 Vaccines
Dr. Wim van der Helm, MD
EMEA-LATAM Region Europe,
Middle East, Africa and Latin America
Dr. Hans-Joachim Degen
International Product Manager,
Infectious Diseases, Viral Hepatitis and COVID-19
Roche Diagnostics International Ltd
Medical Affairs and
Application Lead Qatar
Roche Diagnostics Middle East
Dr. Anis Yaman
Product Manager – Serum Work Area
Middle East Region
Register now to secure your placeand hear exclusively from the experts on webinar series on SARS-CoV-2 serology testing: Session 5: “Importance of Elecsys Antibody Testing in the context of SARS-CoV-2 Vaccines”
We look forward to welcoming you!
Roche Diagnostics Middle East FZCO
Locally distributed by: Droguerie Omnipharma S.A.L.
Badaro Street – Chaoui Building
P.O. Box 11-7956
Vous devez être connecté pour poster un commentaire.